C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 217/04 (2006.01) A61K 31/47 (2006.01) A61K 31/4725 (2006.01) A61P 25/00 (2006.01) C07D 401/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/12 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2575771
The invention relates to compounds of formula (I) having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5- HT is involved, such as CNS disorders.
L'invention concerne des composés de formule (I), présentant une activité pharmacologique par rapport au récepteur 5-HT7, et plus particulièrement par rapport à certains composés de sulfamide substitués par un tétrahydroisoquinoléine, des procédés permettant de préparer ces composés, des compositions pharmaceutiques comprenant lesdits composés ainsi que leur utilisation pour traiter et prévenir une maladie, telle que des troubles CNS, dans laquelle 5-HT est impliqué.
Buschmann Helmut H.
Dordal Zueras Alberto
Garcia Lopez Monica
Mas Prio Josep
Romero Alonso Luz
Laboratorios Del Dr. Esteve S.a.
Perry + Currier
LandOfFree
5-ht7 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-ht7 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-ht7 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1775142